推荐应用
Tumor Necrosis Factor Receptor II (TNF RII), also known as TNFRSF1B, p75/p80, and CD120b, is a type I transmembrane protein that belongs to the TNF receptor superfamily. It has a molecular weight of approximately 75 kDa. Human TNF RII contains four cysteine-rich repeats in its ECD, which shares 58% and 56% amino acid sequence identity with the mouse and rat orthologs, respectively. Those receptors that lack DDs, like TNF RII, bind TNF Receptor-associated Factors, which transduce signals generated by activation of these receptors. Polymorphisms of the human TNFR2 gene, which result in increased expression of both membrane-bound and soluble TNF RII, have been associated with several autoimmune diseases including Crohn’s disease, systemic lupus erythematosus, and familial rheumatoid arthritis.
高纯度、高活性、低内毒素、高批间一致性

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】HER2与HER3:ErbB受体家族协同靶向治疗的核心工具蛋白
89
2026-08-31
【应用方向】HER2:抗体药物研发的核心工具蛋白
79
2026-08-31
【应用方向】抗体药研发中常见靶点蛋白及其应用
107
2026-08-31
【应用方向】靶点蛋白在抗体药研发中的应用
88
2026-08-31
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
1811
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
1798
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
1087
2026-04-22
【应用方向】TNFR蛋白家族概述
1030
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
1178
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
888
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
908
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
946
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
823
2026-04-20
【技术讲解】ADC药物研究相关靶点汇总
19371
2025-07-30
【应用方向】抗体药筛选的关键—靶点蛋白
11560
2025-07-09





